Current Value of Holding

$26.1 Million

Shares

436 Thousand

% of Portfolio

0.04%

Average Buy Price

$84.4

Avg closing price
Price range

38 Jim Simons Biomarin Pharmaceutical - Registered Shares Trades

Jim Simons acquired 436 Thousand Biomarin Pharmaceutical - Registered Shares shares worth $26.1 Million. That's 0.04% of their equity portfolio (506th largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q4 2013. Since then Jim Simons bought shares eighteen more times and sold shares on nineteen occasions. The investor's estimated purchase price is $36.8 Million, resulting in a loss of 29%.

Avg closing price
Price range
Increased shares by 4.1% (+17 Thousand shares) Q4 2024
Avg closing price $66.95
Price range $61.93 - $70.53
Increased shares by 260.5% (+303 Thousand shares) Q3 2024
Avg closing price $83.67
Price range $69.02 - $93.84
Sold 78.6% shares (-426 Thousand shares) Q2 2024
Avg closing price $83.25
Price range $74.43 - $92.22
Increased shares by 40.2% (+155 Thousand shares) Q1 2024
Avg closing price $89.52
Price range $83.81 - $99.00
Sold 33.5% shares (-195 Thousand shares) Q4 2023
Avg closing price $88.47
Price range $76.22 - $98.51
Sold 20.6% shares (-151 Thousand shares) Q3 2023
Avg closing price $88.98
Price range $85.07 - $94.48
Sold 6.2% shares (-48.4 Thousand shares) Q2 2023
Avg closing price $94.11
Price range $86.68 - $100.30
Increased shares by 23.9% (+151 Thousand shares) Q1 2023
Avg closing price $103.67
Price range $87.74 - $117.27
Sold 15.3% shares (-114 Thousand shares) Q4 2022
Avg closing price $93.88
Price range $80.93 - $108.63
Increased shares by 1.3% (+9.71 Thousand shares) Q3 2022
Avg closing price $89.04
Price range $82.16 - $96.94
Increased shares by 49.6% (+244 Thousand shares) Q2 2022
Avg closing price $79.62
Price range $71.48 - $86.85
Sold 24.6% shares (-160 Thousand shares) Q1 2022
Avg closing price $83.67
Price range $74.28 - $92.69
Increased shares by 70.7% (+270 Thousand shares) Q4 2021
Avg closing price $82.51
Price range $71.72 - $91.47
Increased shares by 31.6% (+91.5 Thousand shares) Q3 2021
Avg closing price $78.90
Price range $74.77 - $85.47
Sold 20.7% shares (-75.6 Thousand shares) Q2 2021
Avg closing price $79.27
Price range $75.51 - $84.79
New holding (+366 Thousand shares) Q1 2021
Avg closing price $81.69
Price range $74.73 - $90.69
Sold -19.1 Thousand shares Q2 2020
Avg closing price $99.39
Price range $79.55 - $124.22
Sold 90.6% shares (-183 Thousand shares) Q1 2020
Avg closing price $86.16
Price range $71.37 - $96.85
Sold 63.6% shares (-354 Thousand shares) Q4 2019
Avg closing price $75.53
Price range $64.27 - $86.37
Increased shares by 3.5% (+18.7 Thousand shares) Q3 2019
Avg closing price $77.02
Price range $67.40 - $85.11

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!